These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 18008002)

  • 1. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth.
    Apelberg BJ; Witter FR; Herbstman JB; Calafat AM; Halden RU; Needham LL; Goldman LR
    Environ Health Perspect; 2007 Nov; 115(11):1670-6. PubMed ID: 18008002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.
    Olsen GW; Butenhoff JL; Zobel LR
    Reprod Toxicol; 2009 Jun; 27(3-4):212-230. PubMed ID: 19429401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland.
    Apelberg BJ; Goldman LR; Calafat AM; Herbstman JB; Kuklenyik Z; Heidler J; Needham LL; Halden RU; Witter FR
    Environ Sci Technol; 2007 Jun; 41(11):3891-7. PubMed ID: 17612165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth.
    Washino N; Saijo Y; Sasaki S; Kato S; Ban S; Konishi K; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
    Environ Health Perspect; 2009 Apr; 117(4):660-7. PubMed ID: 19440508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort.
    Fei C; McLaughlin JK; Tarone RE; Olsen J
    Environ Health Perspect; 2007 Nov; 115(11):1677-82. PubMed ID: 18008003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.
    Inoue K; Okada F; Ito R; Kato S; Sasaki S; Nakajima S; Uno A; Saijo Y; Sata F; Yoshimura Y; Kishi R; Nakazawa H
    Environ Health Perspect; 2004 Aug; 112(11):1204-7. PubMed ID: 15289168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.
    Itoh S; Araki A; Mitsui T; Miyashita C; Goudarzi H; Sasaki S; Cho K; Nakazawa H; Iwasaki Y; Shinohara N; Nonomura K; Kishi R
    Environ Int; 2016 Sep; 94():51-59. PubMed ID: 27209000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study.
    Kishi R; Nakajima T; Goudarzi H; Kobayashi S; Sasaki S; Okada E; Miyashita C; Itoh S; Araki A; Ikeno T; Iwasaki Y; Nakazawa H
    Environ Health Perspect; 2015 Oct; 123(10):1038-45. PubMed ID: 25840032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls.
    Maisonet M; Terrell ML; McGeehin MA; Christensen KY; Holmes A; Calafat AM; Marcus M
    Environ Health Perspect; 2012 Oct; 120(10):1432-7. PubMed ID: 22935244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer.
    Beesoon S; Webster GM; Shoeib M; Harner T; Benskin JP; Martin JW
    Environ Health Perspect; 2011 Nov; 119(11):1659-64. PubMed ID: 21757419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isomers of perfluorooctanesulfonate (PFOS) in cord serum and birth outcomes in China: Guangzhou Birth Cohort Study.
    Li M; Zeng XW; Qian ZM; Vaughn MG; Sauvé S; Paul G; Lin S; Lu L; Hu LW; Yang BY; Zhou Y; Qin XD; Xu SL; Bao WW; Zhang YZ; Yuan P; Wang J; Zhang C; Tian YP; Nian M; Xiao X; Fu C; Dong GH
    Environ Int; 2017 May; 102():1-8. PubMed ID: 28297681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010.
    Darrow LA; Stein CR; Steenland K
    Environ Health Perspect; 2013 Oct; 121(10):1207-13. PubMed ID: 23838280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure.
    Gallo V; Leonardi G; Genser B; Lopez-Espinosa MJ; Frisbee SJ; Karlsson L; Ducatman AM; Fletcher T
    Environ Health Perspect; 2012 May; 120(5):655-60. PubMed ID: 22289616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between perfluorinated compound concentrations in cord serum and birth weight using multiple regression models.
    Lee ES; Han S; Oh JE
    Reprod Toxicol; 2016 Jan; 59():53-9. PubMed ID: 26562669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants.
    Okada E; Sasaki S; Saijo Y; Washino N; Miyashita C; Kobayashi S; Konishi K; Ito YM; Ito R; Nakata A; Iwasaki Y; Saito K; Nakazawa H; Kishi R
    Environ Res; 2012 Jan; 112():118-25. PubMed ID: 22030285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in Uyghurs from Sinkiang-Uighur Autonomous Region, China: background levels study.
    Zeng XW; Qian Z; Vaughn M; Xian H; Elder K; Rodemich E; Bao J; Jin YH; Dong GH
    Environ Sci Pollut Res Int; 2015 Mar; 22(6):4736-46. PubMed ID: 25339531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.
    Toms LM; Thompson J; Rotander A; Hobson P; Calafat AM; Kato K; Ye X; Broomhall S; Harden F; Mueller JF
    Environ Int; 2014 Oct; 71():74-80. PubMed ID: 24980755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal-maternal factors and perfluoroalkyl substances in cord blood.
    Lien GW; Huang CC; Wu KY; Chen MH; Lin CY; Chen CY; Hsieh WS; Chen PC
    Chemosphere; 2013 Aug; 92(7):843-50. PubMed ID: 23689097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2008.
    Uhl SA; James-Todd T; Bell ML
    Environ Health Perspect; 2013 Apr; 121(4):447-52. PubMed ID: 23410534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between maternal perfluoroalkyl substance levels, polymorphisms of receptor genes, and adverse birth outcomes in the Hokkaido birth cohort study, Japan.
    Kobayashi S; Sata F; Ikeda-Araki A; Miyashita C; Goudarzi H; Iwasaki Y; Nakajima T; Kishi R
    Reprod Toxicol; 2022 Jan; 107():112-122. PubMed ID: 34896592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.